The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
Open accessAbstract
Fucoidan is a natural derived compound found in different species of brown algae and in some animals, that has gained attention for its anticancer properties. However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relation to its anti-cancer mechanisms. The general bioactivity of fucoidan is difficult to establish due to factors like species-related structural diversity, growth conditions, and the extraction method. The main pathways influenced by fucoidan are the PI3K/AKT, the MAPK pathway, and the caspase pathway. PTEN seems to be important in the fucoidan-mediated effect on the AKT pathway. Furthermore, the interaction with VEGF, BMP, TGF-β, and estrogen receptors are discussed. Also, fucoidan as an adjunct seems to have beneficial effects, for both the enhanced effectiveness of chemotherapy and reduced toxicity in healthy cells. In conclusion, the multipotent character of fucoidan is promising in future anti-cancer treatment. However, there is a need for more specified studies of the structure–activity relationship of fucoidan from the most promising seaweed species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626 · cited 2×
“Cytochrome C (Cyt c) is released from the mitocho dria, regula e by m ltiple members of the Bcl-2 f mily (Figure 2) [138,139].”
BackgroundNatural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Chen, D., Zhao, M., & Mundy, G. R. (2004) · Growth Factors · doi:10.1080/08977190412331279890 · Cited by 1,915
Cited by
Mohammed, A. S. A., Naveed, M., & Jost, N. (2021) · Journal of Polymers and the Environment · doi:10.1007/s10924-021-02052-2 · Cited by 602
Seaweeds as a Functional Ingredient for a Healthy Diet
Peñalver, R., Lorenzo, J. M., Ros, G., Amarowicz, R., Pateiro, M., & Nieto, G. (2020) · Marine Drugs · doi:10.3390/md18060301 · Cited by 488
Advanced Technologies for the Extraction of Marine Brown Algal Polysaccharides
Dobrinčić, A., Balbino, S., Zorić, Z., Pedisić, S., Bursać Kovačević, D., Elez Garofulić, I., & Dragović-Uzelac, V. (2020) · Marine Drugs · doi:10.3390/md18030168 · Cited by 326
Hydrogel-Forming Algae Polysaccharides: From Seaweed to Biomedical Applications
Beaumont, M., Tran, R., Vera, G., Niedrist, D., Rousset, A., Pierre, R., Shastri, V. P., & Forget, A. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.0c01406 · Cited by 320
Jönsson, M., Allahgholi, L., Sardari, R. R. R., Hreggviðsson, G. O., & Nordberg Karlsson, E. (2020) · Molecules · doi:10.3390/molecules25040930 · Cited by 287
Liu, X., Zhang, Y., Li, W., Zhang, B., Yin, J., Liuqi, S., Wang, J., Peng, B., & Wang, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c06417 · Cited by 284
Therapies from Fucoidan: New Developments
Fitton, J. H., Stringer, D. N., Park, A. Y., & Karpiniec, S. S. (2019) · Marine Drugs · doi:10.3390/md17100571 · Cited by 225
Ye, J., Chen, D., Ye, Z., Huang, Y., Zhang, N., Lui, E. M. K., Xue, C., & Xiao, M. (2020) · Marine Drugs · doi:10.3390/md18060328 · Cited by 75
“Fucoidan is a kind of fucose-containing sulfated polysaccharide, found in the fiber pile cell walls and intercellular spaces of brown seaweeds and echinoderm [3].”
BackgroundUsov, A. I., Bilan, M. I., Ustyuzhanina, N. E., & Nifantiev, N. E. (2022) · Marine Drugs · doi:10.3390/md20100638 · Cited by 68
Nagahawatta, D. P., Liyanage, N. M., Jayawardhana, H. H. A. C. K., Lee, H.-G., Jayawardena, T., & Jeon, Y.-J. (2022) · Marine Drugs · doi:10.3390/md20070413 · Cited by 43
“Excessive and continuous inflammatory responses can have a negative impact on the host, leading to tissue damage [11,12].”
BackgroundOral Fucoidan Improves Muscle Size and Strength in Mice
McBean, S. E., Church, J. E., Thompson, B. K., Taylor, C. J., Fitton, J. H., Stringer, D. N., Karpiniec, S. S., Park, A. Y., & Poel, C. (2021) · Physiological Reports · doi:10.14814/phy2.14730 · Cited by 19
Metadata
- Authors
- Van Weelden, G., Bobiński, M., Okła, K., Van Weelden, W. J., Romano, A., & Pijnenborg, J. M. A.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-01-07
- Volume
- 17
- Issue
- 1
- Pages
- 32
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W2908498115
- Cited by
- 330
- References
- 192
- FWCI
- 28.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.